Draft genomes of non-nitrogen-fixing Frankia strains.

Carlos-Shanley C, Guerra T and Hahn D (2021).

J Genomics.

DOI:

10.7150/jgen.65429

PubMed:

34703504

An α-D-galactan and a β-D-glucan from the mushroom Amanita muscaria: Structural characterization and antitumor activity against melanoma.

Zavadinack M et al (2021).

Carbohydr Polym.

DOI:

10.1016/j.carbpol.2021.118647

PubMed:

34702466

Abutilon indicum Exhibits Anxiolytic and Antidepressant Effects in Mice Models.

Researchers investigated the antidepressant potential of the crude methanolic extract of Abutilon indicum Linn (A. indicum). Tests on Swiss-albino mice showed that A. indicum has significant dose-dependent antidepressant and anxiolytic potential, which peaks at the highest dose. A. indicum has significant pharmacological potential against anxiety and depression.

Zhou X et al (2021).

Dokl Biochem Biophys.

DOI:

10.1134/S1607672921050203

PubMed:

34697741

Artificial selection optimizes clonality in chaya (Cnidoscolus aconitifolius).

Munguía-Rosas MA et al (2021).

Sci Rep.

DOI:

10.1038/s41598-021-00592-0

PubMed:

34697356

More Than Just a Weed: An Exploration of the Antimicrobial Activity of Rumex crispus using a Multivariate Data Analysis Approach.

Pelzer CV et al (2022).

Planta Med.

DOI:

10.1055/a-1652-1547

PubMed:

34695862

Effects of polystyrene microplastics on the seed germination of herbaceous ornamental plants.

Guo M et al (2022).

Sci Total Environ.

DOI:

10.1016/j.scitotenv.2021.151100

PubMed:

34695466

Efficacy of Hibiscus sabdariffa on Reducing Blood Pressure in Patients With Mild-to-Moderate Hypertension: A Systematic Review and Meta-Analysis of Published Randomized Controlled Trials.

Hibiscus sabdariffa significantly reduces blood pressure in patients with mild-to-moderate hypertension, but not in patients with metabolic syndrome or when compared to antihypertensive drugs. More research is needed for long-term efficacy.

Abdelmonem M et al (2022).

J Cardiovasc Pharmacol.

DOI:

10.1097/FJC.0000000000001161

PubMed:

34694241

Removal of COVID-19 Spike Protein, Whole Virus, Exosomes, and Exosomal MicroRNAs by the Hemopurifier® Lectin-Affinity Cartridge in Critically Ill Patients With COVID-19 Infection.

Two critically ill COVID-19 patients were treated with a Hemopurifier, which removes mannosylated viruses and exosomes released by activated cells. Both patients tolerated the treatment well. In one patient, removal of exosomes was associated with improved coagulopathy, oxygenation, and clinical recovery. In the second patient, removal of COVID-19 by the Hemopurifier was observed. The Hemopurifier is currently being further investigated in a safety and feasibility study with up to 40 patients in ICU with COVID-19 infection.

Amundson DE et al (2021).

Front Med (Lausanne).

DOI:

10.3389/fmed.2021.744141

PubMed:

34692735